18 May 2013
Keywords: ogs, signs, alzheimer, deal, pfizer, oxford, glycosciences
Article | 07 April 1998
Oxford GlycoSciences of the UK has entered into a research collaborationwith US giant Pfizer, using its proteomics technology to identify
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 April 1998
2 April 1998
17 May 2013
© 2013 thepharmaletter.com